Peramivir Intermediate CAS 229613-93-8
China Peramivir Intermediate CAS 229613-93-8, Find details about China Water Content 0.01%, Residue on Ignition from Peramivir Intermediate CAS 229613-93-8
Basic Info.
Effect
Antidepressent
Assay
99.1%
Annul Sales
2000kg
Package
Drums
Residual Solvent
Ethanol
Sample
Free
Heavy Metal
10ppm
Capacity
2500kg
Keyword
Tartaric Acid
Residual Solvents
20ppm
Stock
2000kgs
Usage
Cometics Powder
Skin
Whitening
GMP
Yes
Other Name
3-D]Pyrimidin-4-Ylamine
Trademark
jf
Transport Package
Drun
Specification
ip
Origin
China
HS Code
2099055900
Effect
Antidepressent
Assay
99.1%
Annul Sales
2000kg
Package
Drums
Residual Solvent
Ethanol
Sample
Free
Heavy Metal
10ppm
Capacity
2500kg
Keyword
Tartaric Acid
Residual Solvents
20ppm
Stock
2000kgs
Usage
Cometics Powder
Skin
Whitening
GMP
Yes
Other Name
3-D]Pyrimidin-4-Ylamine
Trademark
jf
Transport Package
Drun
Specification
ip
Origin
China
HS Code
2099055900
Product Desciption
Peramivir api and intermediate
RAPIVAB injection is a clear, colorless, sterile, isotonic solution (200 mg per 20 mL) in glass vials fitted with rubber stoppers and royal blue flip-off seals. Each mL contains 10 mg peramivir (on an anhydrous basis) in 0.9% sodium chloride solution. The pH may have been adjusted with sodium hydroxide, USP and/or hydrochloric acid, USP. The pH is 5.5 - 8.5.
Peramivir is an antiviral agent developed by Biocryst Pharmaceuticals to treat influenza A/B. The development of peramivir has been supported by the US Department of Health and Human Services as part of the government's effort to prepare for a flu pandemic. Being an influenza virus neuraminidase inhibitor, peramivir works by preventing new viruses from emerging from infected cells. Due to the poor oral bioavailability, the oral formulation of the drug was previously abandoned by Johnson and Johnson Company. The injectable intravenous formulation of peramivir was approved by the FDA in September 2017 for the treatment of acute uncomplicated influenza to pediatric patients 2 years and older who have been symptomatic for no more than two days.
RAPIVAB injection is a clear, colorless, sterile, isotonic solution (200 mg per 20 mL) in glass vials fitted with rubber stoppers and royal blue flip-off seals. Each mL contains 10 mg peramivir (on an anhydrous basis) in 0.9% sodium chloride solution. The pH may have been adjusted with sodium hydroxide, USP and/or hydrochloric acid, USP. The pH is 5.5 - 8.5.
Peramivir is an antiviral agent developed by Biocryst Pharmaceuticals to treat influenza A/B. The development of peramivir has been supported by the US Department of Health and Human Services as part of the government's effort to prepare for a flu pandemic. Being an influenza virus neuraminidase inhibitor, peramivir works by preventing new viruses from emerging from infected cells. Due to the poor oral bioavailability, the oral formulation of the drug was previously abandoned by Johnson and Johnson Company. The injectable intravenous formulation of peramivir was approved by the FDA in September 2017 for the treatment of acute uncomplicated influenza to pediatric patients 2 years and older who have been symptomatic for no more than two days.
You Might Also Like
12f- 70 -11640 Loader Machinery Cutting Edge
50 Ton Crane Truck in Dubai for Sale (QY50KA)
Brand New 60tons Mobile Truck Crane (QY60K)
Anti- Acne Skin Beauty Weight Loss Photobiomodulation Light ......
Automatic Tape Edge Machine Manufacture for The Mattress Sew......
2-12 Pin Aviation Plug and Socket M16-M29, Threaded Circular......
Coin-Operated Shooting Gun Simulator Named The Gun of King f......
Reactive Dye Sublimation Ink for Textile Printer on Sales 5L......
Plastic Packing Seal, Plastic Security Seal Round
Wafer Type Butterfly Valve Pneumatic Actuator with Reasonabl......
Vinyl Plotter /Die Cut Plotter /High Precision Stepper Plott......
Bulk Arachidonic Acid Powder Ara Powder 10% 40 % CAS 506-32-......